VC
BIIB icon

V2 Capital’s Biogen BIIB Stock Holding History

V2 Capital’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$1.32M Buy
+3,128
New +$1.23M 0.55% 46

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

V2 Capital's BIIB Position: Q1 2015 in Review

V2 Capital opened a new position in Biogen (BIIB) in Q1 2015: 3,128 shares worth $1.32M. The stake represents 0.55% of the portfolio and ranks #46 among its holdings.

966 funds tracked by Wall St. Rank hold BIIB as of Q1 2015.

  • V2 Capital held 3,128 shares of Biogen worth $1.32M as of Q1 2015.
  • Biogen was a new V2 Capital position in Q1 2015.
  • Biogen made up 0.55% of V2 Capital's portfolio in Q1 2015, its #46 holding.
  • 966 funds tracked by Wall St. Rank held Biogen as of Q1 2015.

Based on V2 Capital's 13F filing for Q1 2015, filed 5 May 2015.